The role of antibodies in HIV vaccines
Licensed vaccines against viral diseases generate antibodies that neutralize the infecting virus and protect against infection or disease. Similarly, an effective vaccine against HIV-1 will likely need to induce antibodies that prevent initial infection of host cells or that limit early events of vi...
Saved in:
| Published in | Annual review of immunology Vol. 28; p. 413 |
|---|---|
| Main Authors | , |
| Format | Journal Article |
| Language | English |
| Published |
United States
01.01.2010
|
| Subjects | |
| Online Access | Get more information |
Cover
Loading…
| Abstract | Licensed vaccines against viral diseases generate antibodies that neutralize the infecting virus and protect against infection or disease. Similarly, an effective vaccine against HIV-1 will likely need to induce antibodies that prevent initial infection of host cells or that limit early events of viral dissemination. Such antibodies must target the surface envelope glycoproteins of HIV-1, which are highly variable in sequence and structure. The first subunit vaccines to enter clinical trails were safe and immunogenic but unable to elicit antibodies that neutralized most circulating strains of HIV-1. However, potent virus neutralizing antibodies (NAbs) can develop during the course of HIV-1 infection, and this is the type of antibody response that researchers seek to generate with a vaccine. Thus, current vaccine design efforts have focused on a more detailed understanding of these broadly neutralizing antibodies and their epitopes to inform the design of improved vaccines. |
|---|---|
| AbstractList | Licensed vaccines against viral diseases generate antibodies that neutralize the infecting virus and protect against infection or disease. Similarly, an effective vaccine against HIV-1 will likely need to induce antibodies that prevent initial infection of host cells or that limit early events of viral dissemination. Such antibodies must target the surface envelope glycoproteins of HIV-1, which are highly variable in sequence and structure. The first subunit vaccines to enter clinical trails were safe and immunogenic but unable to elicit antibodies that neutralized most circulating strains of HIV-1. However, potent virus neutralizing antibodies (NAbs) can develop during the course of HIV-1 infection, and this is the type of antibody response that researchers seek to generate with a vaccine. Thus, current vaccine design efforts have focused on a more detailed understanding of these broadly neutralizing antibodies and their epitopes to inform the design of improved vaccines. |
| Author | Mascola, John R Montefiori, David C |
| Author_xml | – sequence: 1 givenname: John R surname: Mascola fullname: Mascola, John R email: jmascola@nih.gov organization: Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA. jmascola@nih.gov – sequence: 2 givenname: David C surname: Montefiori fullname: Montefiori, David C |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/20192810$$D View this record in MEDLINE/PubMed |
| BookMark | eNo1zstKAzEUgOEgir3oK0g2uoue3DNLKdYWCm6q25LLCUZmMmWmU_DtXairf_fxL8hl7SsScs_hkXNlnnyt04BnVrpuqn3LQIKChnHgQpsLMudaaSaFdTOyGMcvAGiktNdkJoA3wnGYk4f9J9Khb5H2mfp6KqFPBUdaKt1sP-jZx1gqjjfkKvt2xNu_Lsn7-mW_2rDd2-t29bxjXis4MadSzNlZ8Bm0Ml7whqNrsvHBWalVylLlkFOKUkjI4J0T0SBaq0OMKMSS3P26xyl0mA7HoXR--D78D4sfmuNGnw |
| CitedBy_id | crossref_primary_10_1016_j_virol_2012_10_004 crossref_primary_10_1371_journal_pone_0077756 crossref_primary_10_1016_j_antiviral_2013_09_009 crossref_primary_10_1016_j_jelechem_2012_08_004 crossref_primary_10_1016_j_virol_2012_06_025 crossref_primary_10_1146_annurev_immunol_032712_095916 crossref_primary_10_1016_j_coi_2017_06_008 crossref_primary_10_3390_vaccines2020196 crossref_primary_10_1128_JVI_00908_15 crossref_primary_10_1128_JVI_05165_11 crossref_primary_10_1073_pnas_1104840108 crossref_primary_10_1371_journal_ppat_1002721 crossref_primary_10_1038_ncomms1100 crossref_primary_10_1099_vir_0_043802_0 crossref_primary_10_1186_s12977_016_0312_7 crossref_primary_10_1007_s12026_014_8551_y crossref_primary_10_1016_j_virol_2014_06_018 crossref_primary_10_3390_cells13010033 crossref_primary_10_3390_ijms25042432 crossref_primary_10_1371_journal_pone_0097478 crossref_primary_10_1097_COH_0b013e32833d2e90 crossref_primary_10_1016_j_celrep_2017_02_003 crossref_primary_10_1111_j_1747_0285_2012_01423_x crossref_primary_10_1371_journal_pone_0072054 crossref_primary_10_1016_j_celrep_2016_10_085 crossref_primary_10_1038_ni_3158 crossref_primary_10_3389_fimmu_2014_00289 crossref_primary_10_1074_jbc_M111_317776 crossref_primary_10_1128_JVI_00754_11 crossref_primary_10_1371_journal_pone_0049610 crossref_primary_10_1038_s41467_018_07962_9 crossref_primary_10_3389_fimmu_2022_848571 crossref_primary_10_1093_infdis_jiz008 crossref_primary_10_1038_srep46308 crossref_primary_10_1128_JVI_01942_15 crossref_primary_10_1128_JVI_00049_16 crossref_primary_10_1186_1742_4690_10_72 crossref_primary_10_1016_j_jmb_2012_11_010 crossref_primary_10_1097_COH_0000000000000442 crossref_primary_10_1073_pnas_1120059109 crossref_primary_10_1371_journal_ppat_1006074 crossref_primary_10_1038_s41426_018_0175_1 crossref_primary_10_3390_v11040384 crossref_primary_10_1016_j_virol_2014_06_006 crossref_primary_10_4049_jimmunol_1600309 crossref_primary_10_1038_nri2836 crossref_primary_10_1586_erv_10_70 crossref_primary_10_1097_COH_0000000000000095 crossref_primary_10_3389_fbioe_2022_1106767 crossref_primary_10_3390_toxins14020138 crossref_primary_10_1038_nsmb_2194 crossref_primary_10_1097_QAD_0b013e32834d3c4f crossref_primary_10_1007_s00705_011_1053_5 crossref_primary_10_1016_j_molimm_2015_02_026 crossref_primary_10_3390_vaccines1040497 crossref_primary_10_1007_s00425_013_1932_y crossref_primary_10_1039_D2RA08160A crossref_primary_10_1038_nri3488 crossref_primary_10_1016_j_str_2016_06_012 crossref_primary_10_1016_j_virol_2011_08_007 crossref_primary_10_1126_science_1192819 crossref_primary_10_1128_JVI_02380_15 crossref_primary_10_1371_journal_ppat_1006860 crossref_primary_10_4049_jimmunol_1300120 crossref_primary_10_1073_pnas_1217207109 crossref_primary_10_1073_pnas_1208984109 crossref_primary_10_1097_COH_0b013e328363d486 crossref_primary_10_1126_science_aaf1279 crossref_primary_10_1371_journal_pone_0024078 crossref_primary_10_1016_j_vaccine_2011_11_089 crossref_primary_10_1097_QAD_0b013e32835ecb42 crossref_primary_10_1371_journal_ppat_1007024 crossref_primary_10_1038_s41467_024_48139_x crossref_primary_10_1016_j_immuni_2017_05_007 crossref_primary_10_1126_science_1194693 crossref_primary_10_1128_JVI_03309_13 crossref_primary_10_1097_QAD_0000000000001724 crossref_primary_10_1128_JVI_01531_15 crossref_primary_10_1089_aid_2012_0052 crossref_primary_10_1002_cbic_201200119 crossref_primary_10_1016_j_immuni_2011_02_014 crossref_primary_10_1016_j_virol_2017_07_001 crossref_primary_10_1038_514442a crossref_primary_10_1099_vir_0_071522_0 crossref_primary_10_1128_JVI_02083_14 crossref_primary_10_1371_journal_ppat_1005520 crossref_primary_10_1146_annurev_med_050310_085221 crossref_primary_10_1371_journal_pone_0097229 crossref_primary_10_1128_JVI_01110_12 crossref_primary_10_7448_IAS_15_2_17407 crossref_primary_10_1016_j_xphs_2016_07_020 crossref_primary_10_1128_JVI_02321_15 crossref_primary_10_1038_srep36658 crossref_primary_10_1016_j_cell_2014_06_022 crossref_primary_10_1371_journal_pone_0038989 crossref_primary_10_1016_j_virol_2013_07_028 crossref_primary_10_1073_pnas_1315295110 crossref_primary_10_1155_2012_592187 crossref_primary_10_1016_j_virol_2014_03_015 crossref_primary_10_1097_COH_0b013e32833d2cc0 crossref_primary_10_3390_v7102881 crossref_primary_10_1186_1743_422X_9_196 crossref_primary_10_4049_jimmunol_1501243 crossref_primary_10_1073_pnas_1101414108 crossref_primary_10_1038_nature10124 crossref_primary_10_1073_pnas_1214785109 crossref_primary_10_1128_JVI_00063_18 crossref_primary_10_1371_journal_pone_0109196 crossref_primary_10_1016_j_immuni_2017_04_011 crossref_primary_10_1016_j_jim_2013_09_002 crossref_primary_10_1016_j_virol_2011_07_015 crossref_primary_10_1371_journal_ppat_1009543 crossref_primary_10_3390_vaccines4010002 crossref_primary_10_1002_cmdc_201000313 crossref_primary_10_1038_srep19234 crossref_primary_10_1128_JVI_02261_17 crossref_primary_10_1371_journal_pone_0153484 crossref_primary_10_1128_JVI_00552_10 crossref_primary_10_1016_j_pharma_2014_11_003 crossref_primary_10_1089_aid_2010_0177 crossref_primary_10_1128_JVI_02244_10 crossref_primary_10_1073_pnas_1803457115 crossref_primary_10_1371_journal_ppat_1001028 crossref_primary_10_4049_jimmunol_1202165 crossref_primary_10_1074_jbc_M113_529339 crossref_primary_10_1126_scitranslmed_3008992 crossref_primary_10_1128_JVI_00804_12 crossref_primary_10_1073_pnas_1213409109 crossref_primary_10_1111_cei_12692 crossref_primary_10_1093_intimm_dxu055 crossref_primary_10_1073_pnas_1103012108 crossref_primary_10_1128_JVI_00652_15 crossref_primary_10_1128_JVI_01116_16 crossref_primary_10_1080_21645515_2016_1232785 crossref_primary_10_1084_jem_20122824 crossref_primary_10_1371_journal_pone_0041144 crossref_primary_10_1073_pnas_1012923107 crossref_primary_10_1016_j_coi_2012_04_006 crossref_primary_10_1128_JVI_00878_13 crossref_primary_10_1007_s12026_013_8387_x crossref_primary_10_1051_medsci_20143001016 crossref_primary_10_1128_JVI_01739_14 crossref_primary_10_1097_COH_0b013e32834ddc96 crossref_primary_10_1016_j_virol_2017_04_008 crossref_primary_10_1074_jbc_M110_156588 crossref_primary_10_1016_j_drudis_2011_08_013 crossref_primary_10_1038_srep05845 crossref_primary_10_1371_journal_pone_0058927 crossref_primary_10_1038_srep45163 crossref_primary_10_1099_vir_0_042614_0 crossref_primary_10_1128_JVI_00326_11 crossref_primary_10_1097_COH_0b013e32833d2d45 crossref_primary_10_1128_JVI_01111_10 crossref_primary_10_1016_j_vaccine_2012_01_082 crossref_primary_10_1007_s00251_011_0514_z crossref_primary_10_1111_j_1365_2796_2012_02550_x crossref_primary_10_1371_journal_pone_0050529 crossref_primary_10_1097_QAD_0000000000000308 crossref_primary_10_1371_journal_pone_0081002 crossref_primary_10_1111_imr_12512 crossref_primary_10_1016_j_carres_2014_07_012 crossref_primary_10_1128_JVI_03738_14 crossref_primary_10_1084_jem_20120423 crossref_primary_10_1111_imr_12511 crossref_primary_10_1371_journal_pone_0125575 crossref_primary_10_1111_imr_12075 crossref_primary_10_1128_JVI_06363_11 crossref_primary_10_1098_rstb_2011_0096 crossref_primary_10_4049_jimmunol_1300971 crossref_primary_10_1172_JCI80562 crossref_primary_10_1097_QAD_0b013e328359a89d crossref_primary_10_1128_JVI_01653_15 crossref_primary_10_1126_science_1225416 crossref_primary_10_1186_1479_5876_11_48 crossref_primary_10_3390_ijms17091591 crossref_primary_10_1016_j_chom_2012_09_008 crossref_primary_10_1128_JVI_06745_11 crossref_primary_10_1016_j_virol_2017_02_015 crossref_primary_10_1097_COH_0b013e32834ddcd9 crossref_primary_10_1074_jbc_M113_527747 crossref_primary_10_1089_omi_2011_0032 crossref_primary_10_1371_journal_pmed_1002435 crossref_primary_10_1134_S0026893317060176 crossref_primary_10_1172_JCI75894 crossref_primary_10_1128_JVI_02286_10 crossref_primary_10_1038_s41541_022_00514_9 crossref_primary_10_1371_journal_pone_0051633 crossref_primary_10_1128_JVI_01161_13 crossref_primary_10_1371_journal_pone_0115047 crossref_primary_10_1128_JVI_05363_11 crossref_primary_10_1371_journal_pone_0055438 crossref_primary_10_3389_fimmu_2014_00202 crossref_primary_10_1371_journal_ppat_1001225 crossref_primary_10_1089_aid_2015_0041 crossref_primary_10_1016_j_bcp_2022_115285 crossref_primary_10_1126_scitranslmed_3002330 crossref_primary_10_4049_jimmunol_1301283 crossref_primary_10_1038_nri3516 crossref_primary_10_1146_annurev_med_042010_085643 crossref_primary_10_1186_1479_5876_10_144 crossref_primary_10_1016_j_jconrel_2012_01_035 crossref_primary_10_1177_2051013613494534 crossref_primary_10_3390_ijms13055674 crossref_primary_10_1371_journal_ppat_1007431 crossref_primary_10_3389_fimmu_2014_00593 crossref_primary_10_1371_journal_pone_0120648 crossref_primary_10_1097_COH_0000000000000817 crossref_primary_10_1002_rmv_684 crossref_primary_10_1016_j_immuni_2010_09_011 crossref_primary_10_1097_QAD_0000000000000106 crossref_primary_10_1016_j_chom_2021_01_016 crossref_primary_10_1128_JVI_03136_14 crossref_primary_10_1128_JVI_06259_11 crossref_primary_10_1016_j_immuni_2012_08_012 crossref_primary_10_1084_jem_20101176 crossref_primary_10_1016_j_coviro_2015_04_002 crossref_primary_10_1126_scitranslmed_3008104 crossref_primary_10_1007_s00705_011_1145_2 crossref_primary_10_1016_j_molimm_2012_01_003 crossref_primary_10_4161_hv_28950 crossref_primary_10_1007_s10517_019_04504_1 crossref_primary_10_1016_j_virol_2012_01_011 crossref_primary_10_1016_j_ebiom_2016_08_045 crossref_primary_10_1371_journal_pone_0209437 crossref_primary_10_1093_infdis_jis478 crossref_primary_10_1128_JVI_02853_13 crossref_primary_10_1128_JVI_06155_11 crossref_primary_10_1371_journal_pone_0082380 crossref_primary_10_1038_cti_2014_22 crossref_primary_10_1371_journal_ppat_1003184 crossref_primary_10_1371_journal_ppat_1002095 crossref_primary_10_1128_JVI_00853_16 crossref_primary_10_1186_1743_422X_8_429 crossref_primary_10_1016_j_cell_2020_06_044 crossref_primary_10_3390_vaccines10030384 crossref_primary_10_1093_infdis_jis367 crossref_primary_10_1128_JVI_06938_11 crossref_primary_10_1038_srep20987 crossref_primary_10_1371_journal_pone_0035083 crossref_primary_10_4049_jimmunol_1203087 crossref_primary_10_4049_jimmunol_1601134 crossref_primary_10_1038_icb_2010_118 crossref_primary_10_1038_nrmicro2872 crossref_primary_10_1097_COH_0000000000000363 crossref_primary_10_1186_1743_422X_10_347 crossref_primary_10_1016_j_ebiom_2015_09_001 crossref_primary_10_1128_JVI_01543_12 crossref_primary_10_1128_JVI_01812_14 crossref_primary_10_1128_JVI_02378_14 crossref_primary_10_1371_journal_ppat_1008977 crossref_primary_10_1016_j_antiviral_2013_01_007 crossref_primary_10_3389_fimmu_2018_00329 crossref_primary_10_1016_j_vaccine_2012_01_026 crossref_primary_10_1371_journal_ppat_1004932 crossref_primary_10_3389_fimmu_2019_02968 crossref_primary_10_1097_QAD_0000000000001102 crossref_primary_10_1186_1742_4690_10_114 crossref_primary_10_1371_journal_pone_0037157 crossref_primary_10_1002_eji_201242974 crossref_primary_10_1128_JVI_00411_11 crossref_primary_10_1080_19420862_2016_1270491 crossref_primary_10_1016_j_celrep_2018_06_077 crossref_primary_10_1016_j_tim_2012_08_011 crossref_primary_10_1371_journal_pone_0120847 crossref_primary_10_1089_aid_2018_0097 crossref_primary_10_1021_acs_jcim_1c01143 crossref_primary_10_1080_09205063_2014_940243 crossref_primary_10_1111_imr_12484 crossref_primary_10_1371_journal_pone_0075665 crossref_primary_10_1038_srep06778 crossref_primary_10_1084_jem_20112655 crossref_primary_10_1517_14712598_2012_707177 crossref_primary_10_1016_j_virol_2010_10_032 crossref_primary_10_1016_j_immuni_2018_04_029 crossref_primary_10_1371_journal_pone_0080559 crossref_primary_10_1371_journal_pone_0067484 crossref_primary_10_1002_jps_24154 crossref_primary_10_1016_j_addr_2021_113849 crossref_primary_10_1016_j_coi_2011_04_003 crossref_primary_10_1074_jbc_M117_816447 crossref_primary_10_1371_journal_pone_0084234 crossref_primary_10_1371_journal_ppat_1002611 crossref_primary_10_1016_j_vaccine_2011_06_085 crossref_primary_10_1051_mmnp_20127507 crossref_primary_10_1186_1742_4690_7_76 crossref_primary_10_1371_journal_pone_0064405 crossref_primary_10_1007_s11904_011_0105_5 crossref_primary_10_1016_j_virol_2012_02_001 crossref_primary_10_1089_aid_2013_0191 crossref_primary_10_1128_JVI_02186_14 crossref_primary_10_1016_j_cell_2014_01_052 crossref_primary_10_1080_13543776_2018_1495708 crossref_primary_10_1097_QAD_0000000000001242 crossref_primary_10_1016_j_vaccine_2016_11_063 crossref_primary_10_1371_journal_ppat_1007182 |
| ContentType | Journal Article |
| DBID | CGR CUY CVF ECM EIF NPM |
| DOI | 10.1146/annurev-immunol-030409-101256 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
| DatabaseTitleList | MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine Biology |
| EISSN | 1545-3278 |
| ExternalDocumentID | 20192810 |
| Genre | Journal Article Review |
| GroupedDBID | --- -QD -QH .GJ 0R~ 1KX 23M 36B 39C 3V. 4.4 51A 53G 5FA 5FB 5FC 5FD 5FE 5FF 5FH 5GY 5RE 70K 70N 70Q 70S 70W 79. 7A. 7B- 7X7 85S 88A 88E 88I 8AF 8AO 8C1 8FE 8FH 8FI 8FJ 8NG 8R4 8R5 AABJL AAGWO AAIKC AALHT AALUV AAMNW AAOHI AARJV AAWJP AAYIS AAYJJ ABDBF ABDOG ABGRM ABIPL ABJNI ABKGM ABOCM ABUWG ABVYV ABZNY ACAHA ACDVT ACGFS ACGOD ACMXS ACNCT ACPRK ACQCJ ACRLM ACSOE ADBBV ADEJD ADHEY ADLON ADNJN ADOJD ADSVE AEAIQ AEKBM AENEX AEPIK AEWIE AFCZG AFERR AFKDQ AFKEJ AFKRA AFONB AHIXL AHKZM AHMBA AHVNO AI. AICBU AIDEK AIJFW AJAAW ALAFQ ALIPV ALMA_UNASSIGNED_HOLDINGS AMTJG AOUBY AQQLW ATAUN AZQEC B0M B9D B9E B9F B9G B9H B9L B9N BBNVY BCFVH BENPR BHPHI BJPMW BMYRD BPHCQ BVXVI CCPQU CGR CS3 CUY CVF DWQXO EAP EBC EBD EBS ECM EIF EJD EMB EMK EMOBN EST ESX F-Q F-S F-V F-X F-Y F-Z F5P FIWKU FIXEU FMZAJ FQMFW FT0 FU. FUEKT FXG FYUFA GJQJI GLOEX GNDDA GNUQQ GOAVI GQXMV H13 HCIFZ HMCUK HZ~ H~9 J1V L7B LK8 M0L M1P M22 M2P M7P N9A NHB NPM O9- P0P P2P PQQKQ PROAC PSQYO Q2X RAR RAV RNS SV3 TUS UKHRP UKR UMF VH1 WH7 X7N YSK ZGI ZYWBE ~8M |
| ID | FETCH-LOGICAL-a540t-84dcff870af0546a2191e89f6ab87354df34fbfddc3230f0a882c6ee775bcce22 |
| IngestDate | Tue Oct 15 23:40:03 EDT 2024 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Language | English |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-a540t-84dcff870af0546a2191e89f6ab87354df34fbfddc3230f0a882c6ee775bcce22 |
| PMID | 20192810 |
| ParticipantIDs | pubmed_primary_20192810 |
| PublicationCentury | 2000 |
| PublicationDate | 2010-01-01 |
| PublicationDateYYYYMMDD | 2010-01-01 |
| PublicationDate_xml | – month: 01 year: 2010 text: 2010-01-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Annual review of immunology |
| PublicationTitleAlternate | Annu Rev Immunol |
| PublicationYear | 2010 |
| SSID | ssj0009337 |
| Score | 2.525632 |
| SecondaryResourceType | review_article |
| Snippet | Licensed vaccines against viral diseases generate antibodies that neutralize the infecting virus and protect against infection or disease. Similarly, an... |
| SourceID | pubmed |
| SourceType | Index Database |
| StartPage | 413 |
| SubjectTerms | AIDS Vaccines - immunology Animals Antibodies, Neutralizing - immunology Drug Design Epitopes - immunology HIV Antibodies - immunology Humans |
| Title | The role of antibodies in HIV vaccines |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/20192810 |
| Volume | 28 |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LSwMxEA5WsXgRre8XOagXiba72c32KKIUoT210FvJE_bgttBS0F_vZJPYtWpRL8uSQMjmy05mJvPNIHQpKbNpqAwB4QgGCqeKcM1SEmsKkkEZkzYt37nbSzsD-jxMhqGWvGeXzMStfPuWV_IfVKENcLUs2T8g-zEoNMA74AtPQBiev8Y4hAfCCuVibGMCrQujA1bdnEt7az6t6p8-nf6CsJJbfsgn13qXT2Fz8BCne1OJywUQTD4O3PR5rryP1XsNyuCz4DXQXtLRhMSRq58TRKHnaTtZRh1J9KuMrSYXJn6axF6x2soKcOC5TOGV9Z-8lABEVp3MXBTr6t6lFNihq4ZqLLPCrGddMiGzchyzOrryM7tbOS-b-tmPtWRGlOpEfwdtezsA3ztQd9GaLhpo01UGfW2getfHPOyha0AZW5Tx2OAFyjgvMKCMA8r7aPD02H_oEF_dgnDQkmcko0oaA-KSG1CbUw5HR0tnbZNykbE4ocrE1AijlIzBTDRNDraQTLVmLBFS6ig6QOvFuNBHCIu2bKkELEdJNc0EGLFMZUIqzSPRbnJ2jA7dt44mLoXJKKzCyY89p2hrsW_O0IaBf0afgwI2ExclAO8QOC1u |
| link.rule.ids | 783 |
| linkProvider | National Library of Medicine |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+role+of+antibodies+in+HIV+vaccines&rft.jtitle=Annual+review+of+immunology&rft.au=Mascola%2C+John+R&rft.au=Montefiori%2C+David+C&rft.date=2010-01-01&rft.eissn=1545-3278&rft.volume=28&rft.spage=413&rft_id=info:doi/10.1146%2Fannurev-immunol-030409-101256&rft_id=info%3Apmid%2F20192810&rft_id=info%3Apmid%2F20192810&rft.externalDocID=20192810 |